Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-29

Clinical Trial Update: Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)] [Phase 2]

View source ↗

Summary

Phase 2 translational biomarker-driven umbrella study in head and neck squamous cell carcinoma and head and neck neoplasms completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Hospital | Conditions: HNSCC, Head and Neck Neoplasms | Phase 2 | Status: COMPLETED